France-based Median Technologies will showcase its developments for eyonis alongside the company's AI-powered clinical trial imaging services at the 2024 European Congress of Radiology (ECR) in Vienna, from 28 February to 3 March.
At ECR 2024, the company will give two Lightning Talk presentations as well as have a scientific poster available for viewing. These include the following:
- “Eyonis LCS: Revealing Independent Verification Results & Advancements in Clinical Validation Studies," AI Theater Industry Sessions/AI Lightning Talks 2 (AI exhibition, Expo X1), 28 February, 12:30 p.m. CET.
- “Eyonis AI tech-based CADe/CADx device suite: unveiling independent verification results in Lung Cancer Screening & preliminary Hepatocellular carcinoma diagnosis results," AI Theater Industry Sessions/AI Lightning Talks 5 (AI exhibition, Expo X1), 29 February, 12:50 p.m. CET.
- Scientific poster “Developing a novel computer-aided diagnostic technique based on deep learning and CT images for early HCC diagnosis."
Median’s eyonis and iCRO/Imaging Lab teams will be available at booth #AI-17, AI Exhibition, Expo X1 for the duration of the industry exhibition.
